• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Time-restricted eating does not confer changes in sleep, mood, or quality of life

bySiwen LiuandAlex Chan
July 4, 2025
in Chronic Disease, Gastroenterology, Neurology
Reading Time: 2 mins read
Provision of medically-tailored meals linked with lower admissions and medical spending
Share on FacebookShare on TwitterShare on LinkedIn

1. Time-restricted eating, regardless of timing of the eating window, did not result in significant changes in sleep, mood, or quality of life compared with usual care alone.

Evidence Rating Level: 2 (Good)

Although time-restricted eating (TRE) is a promising dietary approach for weight loss, it is unknown whether the timing of the eating window affects sleep, mood, and quality of life differently. This study thus examined whether three TRE schedule were associated with changes in sleep, mood, and quality of life compared with usual care (UC) alone in adults with overweight or obesity. This was a secondary analysis of adults aged 30 to 60 years with overweight or obesity from a parallel-group randomized clinical trial conducted in Granada (southern Spain) and Pamplona (northern Spain) between April 11, 2022, and March 6, 2023. Participants were randomized 1:1:1:1 to either the UC group (daily eating window of ≥12 hours & Mediterranean diet education program), early TRE group (8-hour eating window starting before 10 am), late TRE group (8-hour eating window starting after 1 pm), or self-selected TRE (chose own 8-hour eating window). Sleep, mood, and quality were assessed at baseline and after the 12-week intervention. In total, 197 participants were included (mean [SD] age, 46.1 [8.4] years; 98 women [49.7%]; mean [SD] body mass index, 32.8 [3.2] kg/m2), with 49 in the UC group, 49 in the early TRE group, 52 in the late TRE group, and 47 in the self-selected TRE group. Compared to the UC group, the early TRE group did not significantly differ in sleep (mean difference in total sleep time, 0.2 [95% CI, –0.2 to 0.6] hours), mood (mean difference in Beck Depression Inventory Fast Screen score, 0.2 [95% CI, –1.0 to 1.3] points; mean difference in state anxiety score on the State-Trait Anxiety Inventory, –1.2 [95% CI, –6.4 to 4.1] points; mean difference in Perceived Stress Scale score, 2.1 [95% CI, –1.8 to 5.9] points), and quality of life (mean difference in general health score on the Rand 36-Item Short Form Health Survey, 3.3 [95% CI, –4.4 to 10.9] points). There were also no significant differences when comparing late TRE and self-selected TRE groups to the UC group, as well as between TRE groups. Overall, this study found that in adults with overweight or obesity, including TRE into a UC intervention, regardless of the timing of the eating window, did not lead to significant changes in sleep, mood, or quality of life compared with UC alone. These findings suggest that TRE may be an effective weight management strategy without adversely affecting overall sleep health and psychological well-being. Future studies should confirm these results in larger populations and among those with specific sleep disturbances or mood disorders.

Click to read the study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

Tags: dietGastroenterologyneurologynutritionsleep
Previous Post

Commonly cited medication triggers may not increase risk of microscopic colitis among older adults

Next Post

Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke

RelatedReports

A sleeping child with electrodes on the scalp, surrounded by a moon and night sky, illustrating sleep monitoring and brain health assessment.
Artificial Intelligence

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

October 19, 2026
A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.
Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026
An older adult using a cane as he walks along a broken pathway, with images of a brain and EEG readings in the background, emphasizing mobility and neurological health.
Chronic Disease

Exercise and nutritional support reduce mobility disability in frail older adults

October 5, 2026
A healthcare professional contemplates while surrounded by images of a human silhouette, a hospital, and a physician interacting with a child and parent, indicating pediatric care.
Longevity

A machine-learning diet score identifies eating patterns associated with lower aging-related mortality

October 1, 2026
Next Post
Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke

2 Minute Medicine Rewind July 7, 2025

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Care recommendations by large language models were associated with higher healthcare costs
  • FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer
  • In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.